13/02/2015
Research Suggests HRT Link To Ovarian Cancer
New research from the University of Oxford has found that hormone replacement therapy (HRT) can increase the risk of ovarian cancer.
Professor Sir Richard Peto, leader researcher of the study, said they found an extra case for every 1,000 women taking the drugs for five years from the age of 50, and added claims that short courses of HRT were risk-free, "simply isn't true".
Currently women in the UK take HRT, which is used to alleviate symptoms of the menopause, for between two and five years.
The drugs are known to increase the risk of breast cancer, while also reducing the risk of osteoporosis and bowel cancers.
Their effect on ovarian cancer has always been debated.
Speaking about the study, which was published in the Lancet, Prof Peto, said that "about a million women in this country have HRT and 1,000 will get ovarian cancer from it".
However, according to a report by the BBC, the Institute of Cancer Research in London, said the research showed a "modest increase on a relatively uncommon cancer".
(MH/IT)
Professor Sir Richard Peto, leader researcher of the study, said they found an extra case for every 1,000 women taking the drugs for five years from the age of 50, and added claims that short courses of HRT were risk-free, "simply isn't true".
Currently women in the UK take HRT, which is used to alleviate symptoms of the menopause, for between two and five years.
The drugs are known to increase the risk of breast cancer, while also reducing the risk of osteoporosis and bowel cancers.
Their effect on ovarian cancer has always been debated.
Speaking about the study, which was published in the Lancet, Prof Peto, said that "about a million women in this country have HRT and 1,000 will get ovarian cancer from it".
However, according to a report by the BBC, the Institute of Cancer Research in London, said the research showed a "modest increase on a relatively uncommon cancer".
(MH/IT)
Related UK National News Stories
Click here for the latest headlines.
08 August 2003
HRT therapy can double breast cancer risk
Certain kinds of hormone replacement therapy (HRT) can double a woman's risk of breast cancer, according to major research study of more than a million women. Researchers found that post-menopausal women using combination HRT were twice as likely to develop breast cancer as non-users.
HRT therapy can double breast cancer risk
Certain kinds of hormone replacement therapy (HRT) can double a woman's risk of breast cancer, according to major research study of more than a million women. Researchers found that post-menopausal women using combination HRT were twice as likely to develop breast cancer as non-users.
25 March 2014
Cancer Research UK Raises Over £8m In Six Days
Cancer Research UK has raised over £8 million in donations in just six days thanks to the #nomakeupselfie trend. The #nomakeupselfie trend isn't something Cancer Research UK started.
Cancer Research UK Raises Over £8m In Six Days
Cancer Research UK has raised over £8 million in donations in just six days thanks to the #nomakeupselfie trend. The #nomakeupselfie trend isn't something Cancer Research UK started.
11 August 2003
HRT users at greater risk of breast cancer, says research
Some kinds of hormone replacement therapy (HRT) have a much greater effect on a woman's risk of breast cancer than others, according to research published in the Lancet.
HRT users at greater risk of breast cancer, says research
Some kinds of hormone replacement therapy (HRT) have a much greater effect on a woman's risk of breast cancer than others, according to research published in the Lancet.
23 June 2003
Scientists identify gene that can 'stop' ovarian cancer
Cancer Research UK scientists have claimed to have isolated a gene that has the power to stop ovarian cancer developing, according to a report published yesterday. Researchers found that the gene, known as OPCML, was "switched off" in almost 90% of the ovarian tumours that were tested.
Scientists identify gene that can 'stop' ovarian cancer
Cancer Research UK scientists have claimed to have isolated a gene that has the power to stop ovarian cancer developing, according to a report published yesterday. Researchers found that the gene, known as OPCML, was "switched off" in almost 90% of the ovarian tumours that were tested.
05 August 2005
Breast cancer HRT risk lower than thought
A woman’s risk of developing breast cancer while taking hormone replacement therapy (HRT) might be lower than previously thought, according to new research.
Breast cancer HRT risk lower than thought
A woman’s risk of developing breast cancer while taking hormone replacement therapy (HRT) might be lower than previously thought, according to new research.
-
Northern Ireland WeatherToday:Gale, coastal severe gale, northwest winds ease from late afternoon. Scattered showers will fall as snow over the hills at first, becoming isolated from mid-afternoon. Maximum temperature 7 °C.Tonight:Showers, scattered in the evening, will clear by midnight leaving the night dry with clear spells. Cloud will spread east towards morning. Minimum temperature 2 °C.